Detalhe da pesquisa
1.
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.
Blood
; 142(8): 700-710, 2023 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319437
2.
A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors.
Pediatr Blood Cancer
; 67(4): e28134, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31876107
3.
CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRß repertoire.
Blood
; 125(25): 3835-50, 2015 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25852054
4.
In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial.
Biol Blood Marrow Transplant
; 19(11): 1638-49, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24047754
5.
Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.
Blood Adv
; 7(10): 2196-2205, 2023 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724508
6.
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease.
Sci Transl Med
; 13(576)2021 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33441422
7.
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.
J Clin Oncol
; 39(17): 1865-1877, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449816
8.
A new polycythaemia vera-associated SOCS3 SH2 mutant (SOCS3F136L) cannot regulate erythropoietin responses.
Br J Haematol
; 147(4): 450-8, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19735488
9.
SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases.
Haematologica
; 94(4): 576-80, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19229050
10.
Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies.
Bone Marrow Transplant
; 58(11): 1264-1266, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580397
11.
Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.
Blood Adv
; 7(16): 4395-4399, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285800
12.
Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.
Bone Marrow Transplant
; 58(11): 1260-1263, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580396
13.
The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3.
Blood
; 109(11): 4924-9, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17317861
14.
Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase.
J Virol
; 81(7): 3428-36, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17251292